Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congress maintains existing FDA funding levels temporarily

Executive Summary

Unable to work out a deal to pass appropriations measures by the end of the fiscal year, Congress passes a continuing resolution Sept. 30, maintaining funding for FDA and other federal agencies at fiscal 2010 levels. Resolution expires Dec. 3. If Republicans win a majority in the midterm elections, they may force passage of another continuing resolution that would allow them to set spending levels in 2011 after new members take their seats. In regular appropriations legislation, the Senate Appropriations subcommittee with FDA oversight appropriated $261.5 mil. for the Center for Food Safety and Applied Nutrition and $357 mil. for the Center for Drug Evaluation and Research, both increases over last fiscal year. The House has not yet marked up its version of the agriculture appropriations bill, so funding for individual FDA centers was not known (1"The Rose Sheet" Aug. 2, 2010)
Advertisement

Related Content

FDA Funding Stalls As Chances Grow For Omnibus Or Continuing Resolution
FDA Funding Stalls As Chances Grow For Omnibus Or Continuing Resolution
Advertisement
UsernamePublicRestriction

Register

RS017225

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel